AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33967202 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine + platinum combination therapy
Number of subjects: 18
Study 33967202 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine maintenance therapy
Number of subjects: 18
Study 33040510 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic assisted lateral neck dissection
Number of subjects: 36
Study 33040510 — intervention group
Group type: COMPARATOR
Intervention: Open lateral neck dissection
Number of subjects: 36
Study 35785485 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity continuous (MIC) exercise
Number of subjects: 24
Study 35785485 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval exercise (HIIE)
Number of subjects: 24
Study 35785485 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load high-repetition (LLHR) resistance exercise
Number of subjects: 24
Study 34092664 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (4, 12, 16 U/kg, maximum 100, 300, 400 U)
Number of subjects: 311
Study 32915506 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led smartphone-based self-management programme (Care4Diabetes application)
Number of subjects: 40
Study 32915506 — intervention group
Group type: COMPARATOR
Intervention: Currently available nurse-led diabetes service
Number of subjects: 40
Study 34216468 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-PCR positive/seronegative
Number of subjects: 592
Study 34216468 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-PCR positive/seropositive
Number of subjects: 592
Study 34216468 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seropositive
Number of subjects: 592
Study 34216468 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of SARS-CoV-2 antibodies
Number of subjects: 592
Study 34121364 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation condition
Number of subjects: 120
Study 34121364 — intervention group
Group type: COMPARATOR
Intervention: Stress condition
Number of subjects: 120
Study 32009491 — intervention group
Group type: EXPERIMENTAL
Intervention: Group STOR (shown the operating room)
Number of subjects: 90
Study 32009491 — intervention group
Group type: COMPARATOR
Intervention: Group No STOR (not shown the operating room)
Number of subjects: 90
Study 32009491 — intervention group
Group type: EXPERIMENTAL
Intervention: Group STOR
Number of subjects: 90
Study 32009491 — intervention group
Group type: COMPARATOR
Intervention: Group No STOR
Number of subjects: 90
Study 35449818 — intervention group
Group type: EXPERIMENTAL
Intervention: Copaiba oil (CPO) inhalation
Number of subjects: 22
Study 35449818 — intervention group
Group type: COMPARATOR
Intervention: Jojoba oil (control)
Number of subjects: 22
Study 35414601 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful reperfusion (eTICI ≥2b)
Number of subjects: 192
Study 35414601 — intervention group
Group type: COMPARATOR
Intervention: Unsuccessful reperfusion (eTICI <2b)
Number of subjects: 192
Study 34481311 — intervention group
Group type: EXPERIMENTAL
Intervention: Video conferencing on an electronic device
Number of subjects: 112
Study 34481311 — intervention group
Group type: EXPERIMENTAL
Intervention: Video conferencing tool
Number of subjects: 112
Study 34481311 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face interaction
Number of subjects: 112
Study 32160422 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine + 10 mg samidorphan tablets (OLZ/SAM)
Number of subjects: 234
Study 32160422 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine + placebo tablets (olanzapine)
Number of subjects: 234
Study 35702033 — intervention group
Group type: EXPERIMENTAL
Intervention: Active promotion through social media channels
Number of subjects: 48
Study 35702033 — intervention group
Group type: COMPARATOR
Intervention: No active promotion
Number of subjects: 48
Study 34600270 — intervention group
Group type: EXPERIMENTAL
Intervention: hHW (71 °C water)
Number of subjects: 8
Study 34600270 — intervention group
Group type: EXPERIMENTAL
Intervention: hPAA (400 ppm)
Number of subjects: 8
Study 34600270 — intervention group
Group type: EXPERIMENTAL
Intervention: hDBDMH600 (400 or 600 ppm hypobromous acid)
Number of subjects: 8
Study 34600270 — intervention group
Group type: COMPARATOR
Intervention: hAW (ambient water)
Number of subjects: 8
Study 34600270 — intervention group
Group type: EXPERIMENTAL
Intervention: Other interventions (3% lactic acid, 400 ppm peracetic acid, acidified 400 ppm peracetic acid)
Number of subjects: 8
Study 32022434 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin treatment
Number of subjects: 0
Study 35546060 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for nursing staff on appropriate medication therapy and guidance to recognize potentially harmful medications and adverse effects
Number of subjects: 227
Study 35546060 — intervention group
Group type: COMPARATOR
Intervention: No additional training for nursing staff (control group)
Number of subjects: 227
Study 32956576 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed calcineurin inhibitor (CNI) substitution
Number of subjects: 225
Study 32956576 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (CNI-based)
Number of subjects: 225
Study 32067132 — intervention group
Group type: EXPERIMENTAL
Intervention: Mnemonic strategy training (n=7), 3-day training, 45-60 minutes per session, focusing on encoding and retrieving information about objects and their locations using labeling, verbal reasoning, and mental imagery.
Number of subjects: 14
Study 32067132 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=7), received care as usual (occupational therapy, music therapy, and exercise).
Number of subjects: 14
Study 32209728 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitrope™ Prefilled Syringe
Number of subjects: 451
Study 32209728 — intervention group
Group type: COMPARATOR
Intervention: Gonal‐F® Pen
Number of subjects: 451
Study 36048113 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative income shock narrative
Number of subjects: 140
Study 36048113 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral income shock narrative
Number of subjects: 140
Study 36048113 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive income shock narrative
Number of subjects: 140
Study 36048113 — intervention group
Group type: COMPARATOR
Intervention: Control (no income shock narrative)
Number of subjects: 140
Study 33881716 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating moxibustion
Number of subjects: 60
Study 33881716 — intervention group
Group type: COMPARATOR
Intervention: Mild moxibustion
Number of subjects: 60
Study 35501846 — intervention group
Group type: EXPERIMENTAL
Intervention: Video tele-education
Number of subjects: 378
Study 35501846 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person education
Number of subjects: 378
Study 35501846 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 378
Study 34406323 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized internal mammary artery graft harvesting
Number of subjects: 0
Study 34406323 — intervention group
Group type: COMPARATOR
Intervention: Pedicled internal mammary artery graft harvesting
Number of subjects: 0
Study 34391243 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape
Number of subjects: 42
Study 34391243 — intervention group
Group type: COMPARATOR
Intervention: Sham Kinesio Tape
Number of subjects: 42
Study 32026745 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack-short (8 questions/survey)
Number of subjects: 121
Study 32026745 — intervention group
Group type: EXPERIMENTAL
Intervention: OnTrack-long (17 questions/survey)
Number of subjects: 121
Study 35753192 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help intervention (two four-session trainings: cognitive training and motivational training)
Number of subjects: 77
Study 35753192 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational training (second four-session training)
Number of subjects: 77
Study 35645070 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezocision procedure (Group II)
Number of subjects: 15
Study 35645070 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 15
Study 32608989 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Approach of Yoga Therapy (IAYT), 3 classes per week for 12 weeks
Number of subjects: 66
Study 32608989 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 66
Study 34958771 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally Invasive (MI) approach
Number of subjects: 358
Study 34958771 — intervention group
Group type: COMPARATOR
Intervention: Full Sternotomy (FS) approach
Number of subjects: 358
Study 32868138 — intervention group
Group type: EXPERIMENTAL
Intervention: dd-MVAC
Number of subjects: 500
Study 32868138 — intervention group
Group type: COMPARATOR
Intervention: GC
Number of subjects: 500
Study 32246717 — intervention group
Group type: EXPERIMENTAL
Intervention: er-MedDiet + PA group
Number of subjects: 75
Study 32246717 — intervention group
Group type: COMPARATOR
Intervention: MedDiet group
Number of subjects: 75
Study 35913983 — intervention group
Group type: EXPERIMENTAL
Intervention: JEV vaccination (mouse brain-derived)
Number of subjects: 873
Study 35913983 — intervention group
Group type: EXPERIMENTAL
Intervention: Living in peri-urban districts
Number of subjects: 873
Study 35913983 — intervention group
Group type: EXPERIMENTAL
Intervention: History of prior dengue virus infection
Number of subjects: 873
Study 35913983 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age and male sex
Number of subjects: 873
Study 35913983 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 873
Study 32281466 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory perceptual training with fluoxetine (20 mg daily)
Number of subjects: 20
Study 32281466 — intervention group
Group type: COMPARATOR
Intervention: Multisensory perceptual training with placebo
Number of subjects: 20
Study 32281466 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg daily)
Number of subjects: 20
Study 32281466 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory perceptual training
Number of subjects: 20
Study 34694154 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position (SUP)
Number of subjects: 112
Study 34694154 — intervention group
Group type: COMPARATOR
Intervention: Prone position (PRO)
Number of subjects: 112
Study 32791048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib maintenance (400 mg orally twice daily)
Number of subjects: 202
Study 32791048 — intervention group
Group type: COMPARATOR
Intervention: Control (non-maintenance)
Number of subjects: 202
Study 32791048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib maintenance
Number of subjects: 202
Study 32588334 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary magnesium supplementation (2, 4, or 6 g/kg MgO)
Number of subjects: 120
Study 35672956 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained specialist treatment (ST)
Number of subjects: 198
Study 35672956 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained specialist treatment including Parent groups (ST + P)
Number of subjects: 198
Study 35672956 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 198
Study 34473834 — intervention group
Group type: COMPARATOR
Intervention: Control group in a stepped‐wedge randomised controlled trial
Number of subjects: 230
Study 34473834 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous hospital admission
Number of subjects: 230
Study 34473834 — intervention group
Group type: EXPERIMENTAL
Intervention: More chronic diseases
Number of subjects: 230
Study 34473834 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in preference during follow-up
Number of subjects: 230
Study 36351310 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil
Number of subjects: 55
Study 36351310 — intervention group
Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 55
Study 33472680 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-elemental formula
Number of subjects: 195
Study 33472680 — intervention group
Group type: COMPARATOR
Intervention: Polymeric formula
Number of subjects: 195
Study 33472680 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 195
Study 32456512 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher HDL-c variability
Number of subjects: 4428
Study 35412432 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education (PNE)
Number of subjects: 29
Study 35412432 — intervention group
Group type: COMPARATOR
Intervention: Biomedical Education (BME)
Number of subjects: 29
Study 33538192 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (patients from 17 PHCs in North Barcelona)
Number of subjects: 1932
Study 33538192 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients from 34 PHCs in South, East and West Barcelona)
Number of subjects: 1932
Study 33538192 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 1932
Study 33538192 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1932
Study 32449960 — intervention group
Group type: EXPERIMENTAL
Intervention: Granola labeled as 'Organic'
Number of subjects: 105
Study 32449960 — intervention group
Group type: EXPERIMENTAL
Intervention: Granola labeled as 'Made with real grains'
Number of subjects: 105
Study 32449960 — intervention group
Group type: EXPERIMENTAL
Intervention: Granola labeled as 'No preservatives'
Number of subjects: 105
Study 32449960 — intervention group
Group type: EXPERIMENTAL
Intervention: Food choice and intake based on labels
Number of subjects: 105
Study 32449960 — intervention group
Group type: EXPERIMENTAL
Intervention: Income level and age
Number of subjects: 105
Study 36482530 — intervention group
Group type: EXPERIMENTAL
Intervention: TLE 400 (efavirenz 400 mg)
Number of subjects: 265
Study 36482530 — intervention group
Group type: COMPARATOR
Intervention: TLE 600 (efavirenz 600 mg)
Number of subjects: 265
Study 33471240 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 147
Study 33175022 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (3 consultations, 30-day intervals)
Number of subjects: 118
Study 33175022 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up in specialized clinics
Number of subjects: 118
Study 34520849 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs focusing on education (33.9% of studies)
Number of subjects: 316
Study 33549682 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-tailored intervention
Number of subjects: 693
Study 33549682 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored brochure
Number of subjects: 693
Study 32664948 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended 6-day course of artemether-lumefantrine and additional single low-dose primaquine (0.25 mg/kg) administered with the last dose.
Number of subjects: 195
Study 32664948 — intervention group
Group type: COMPARATOR
Intervention: Standard weight-based 3-day course of artemether-lumefantrine.
Number of subjects: 195
Study 33275794 — intervention group
Group type: EXPERIMENTAL
Intervention: iClearCyte algorithm
Number of subjects: 214
Study 33275794 — intervention group
Group type: COMPARATOR
Intervention: ClearCyte® system with cytopathologist's review
Number of subjects: 214
Study 32510985 — intervention group
Group type: EXPERIMENTAL
Intervention: PGA (fast polygluconate acid)
Number of subjects: 40
Study 32510985 — intervention group
Group type: COMPARATOR
Intervention: PLLA (slow polylevolactic acid)
Number of subjects: 40
Study 32510985 — intervention group
Group type: EXPERIMENTAL
Intervention: PGA
Number of subjects: 40
Study 32510985 — intervention group
Group type: COMPARATOR
Intervention: PLLA
Number of subjects: 40
Study 35658345 — intervention group
Group type: EXPERIMENTAL
Intervention: PKU‐ML model (machine learning diagnostic model)
Number of subjects: 287
Study 35658345 — intervention group
Group type: COMPARATOR
Intervention: Brock model (control)
Number of subjects: 287
Study 35658345 — intervention group
Group type: COMPARATOR
Intervention: Mayo model (control)
Number of subjects: 287
Study 35658345 — intervention group
Group type: COMPARATOR
Intervention: VA model (control)
Number of subjects: 287
Study 35658345 — intervention group
Group type: COMPARATOR
Intervention: PKUPH model (control)
Number of subjects: 287
Study 33819135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling garment infused with cooled water (18°C) worn underneath FPC
Number of subjects: 12
Study 33819135 — intervention group
Group type: COMPARATOR
Intervention: No cooling (control)
Number of subjects: 12
Study 33835404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep (12- or 24-hour delay with sleep)
Number of subjects: 115
Study 33835404 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness (12- or 24-hour delay without sleep)
Number of subjects: 115
Study 34491443 — intervention group
Group type: EXPERIMENTAL
Intervention: Colored patient rooms
Number of subjects: 80
Study 34491443 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient rooms
Number of subjects: 80
Study 34368923 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Sliding (DS) technique
Number of subjects: 36
Study 34368923 — intervention group
Group type: COMPARATOR
Intervention: Power-arm Sliding (PAS) technique
Number of subjects: 36
Study 34368923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 36
Study 32573912 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise (WG)
Number of subjects: 0
Study 32573912 — intervention group
Group type: COMPARATOR
Intervention: Land-based exercise (LG)
Number of subjects: 0
Study 35997713 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Sleep Deprivation (TSD)
Number of subjects: 48
Study 34347359 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior metformin use
Number of subjects: 1290
Study 34347359 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term metformin use
Number of subjects: 1290
Study 32445077 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (60 mg with 2% lignocaine)
Number of subjects: 67
Study 32445077 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (40 mg with 2% lignocaine)
Number of subjects: 67
Study 32445077 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Ketorolac and Methylprednisolone
Number of subjects: 67
Study 35256446 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 750 mg/day
Number of subjects: 40
Study 35256446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33594439 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) at 100% oxygen at 2.0 atmospheres per session, 5 days per week, for 8 weeks.
Number of subjects: 18
Study 33594439 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment arm (control group) receiving HBOT after a 12-week waiting period.
Number of subjects: 18
Study 36443093 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated Partial Breast Irradiation (APBI) - 5× 6 Gy
Number of subjects: 57
Study 36443093 — intervention group
Group type: COMPARATOR
Intervention: Accelerated Whole Breast Irradiation with boost - 15× 2.67 Gy + 5× 2 Gy
Number of subjects: 57
Study 36443093 — intervention group
Group type: EXPERIMENTAL
Intervention: APBI
Number of subjects: 57
Study 33503497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Prevention Wizard-Clinical Decision Support (CPW-CDS)
Number of subjects: 34
Study 33503497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer Prevention Wizard-Clinical Decision Support plus Shared Decision Making Tools (CPW + SDMTs)
Number of subjects: 34
Study 33503497 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 34
Study 33503497 — intervention group
Group type: EXPERIMENTAL
Intervention: CPW-CDS and CPW + SDMTs
Number of subjects: 34
Study 32650814 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene instruction (OHI)
Number of subjects: 166
Study 32650814 — intervention group
Group type: EXPERIMENTAL
Intervention: OHI, 6-month use of powered tooth brushing, and 0.2% chlorhexidine gluconate mouth rinse (10 ml twice daily)
Number of subjects: 166
Study 34362422 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard statistical analyses for truncated binary outcomes in small studies
Number of subjects: 0
Study 34362422 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing treatment effect on the intermediate variable
Number of subjects: 0
Study 34362422 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength of confounding between the intermediate and outcome variables
Number of subjects: 0
Study 34362422 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of an interaction between treatment and confounder
Number of subjects: 0
Study 32443139 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 76
Study 32443139 — intervention group
Group type: COMPARATOR
Intervention: Codeine
Number of subjects: 76
Study 32443139 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 Genotyping
Number of subjects: 76
Study 35061894 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg once daily)
Number of subjects: 34
Study 35061894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35061894 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 34
Study 33974725 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic powder supplementation (1,600 mg/d for 3 months)
Number of subjects: 90
Study 33201504 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of using cosmetics
Number of subjects: 65
Study 33201504 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of participants
Number of subjects: 65
Study 32680812 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lymphatic drainage (MLD), 6 sessions after surgery
Number of subjects: 26
Study 32680812 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MLD), same postoperative care as intervention group
Number of subjects: 26
Study 33687748 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla‐300)
Number of subjects: 596
Study 33687748 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (IDeg‐100)
Number of subjects: 596
Study 36214350 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical Implantation of the Implantable Collamer Lens (ICL)
Number of subjects: 46